|1.||Evangelista, Laura: 4 articles (10/2015 - 05/2013)|
|2.||Rubello, Domenico: 4 articles (01/2014 - 10/2007)|
|3.||Borsatti, Eugenio: 3 articles (10/2015 - 12/2006)|
|4.||Cimitan, Marino: 3 articles (10/2015 - 12/2006)|
|5.||Treglia, Giorgio: 3 articles (01/2015 - 03/2014)|
|6.||Schillaci, Orazio: 3 articles (12/2013 - 01/2010)|
|7.||Mongiat-Artus, Pierre: 2 articles (11/2015 - 12/2014)|
|8.||Merlet, Pascal: 2 articles (11/2015 - 12/2014)|
|9.||Hodolič, Marina: 2 articles (10/2015 - 02/2015)|
|10.||Fettich, Jure: 2 articles (10/2015 - 02/2015)|
08/01/2015 - "The tumor-to-background ratio in positive scans was higher for (68)Ga-PSMA than for (18)F-fluoromethylcholine (28.6 for (68)Ga-PSMA vs. 9.4 for (18)F-fluoromethylcholine, P < 0.001). "
08/01/2012 - "To evaluate the distribution of 18F-labelled fluoromethylcholine (FCho) in normal structures and tumors of the head region using positron emission tomography (PET) and magnetic resonance imaging. "
08/01/2012 - "Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET/MRI evaluation."
10/01/2009 - "D4-FCH proved more resistant to oxidation than its nondeuterated analogue, [(18)F]fluoromethylcholine, in plasma, kidneys, liver, and tumor, while retaining phosphorylation potential. "
05/01/2008 - "None of the patients with a multifocal or inhomogeneous 18F-choline uptake had a malignant neoplasm in the prostate. "
05/01/2015 - "Asymptomatic metastasis to cricoid from prostate carcinoma: an incidental finding detected on 18F-choline PET/CT."
02/01/2013 - "The detection rate of both 11C-choline and 18F-choline PET and PET/CT for local, regional, and distant recurrence in prostate carcinoma patients with a biochemical recurrence increases with rising PSA value at the time of imaging and reaches about 75% in patients with PSA > 3 ng/mL. Furthermore, PET and PET/CT with [11C]- and [18F]-choline derivates may be helpful in the clinical setting for optimization of individualized treatment."
|3.||Prostatic Neoplasms (Prostate Cancer)
01/01/2015 - "The nonspecific lymph node uptake of 18F-choline in patients with prostate cancer--a prospective observational study."
09/01/2008 - "In patients with biochemical relapse after radical treatment for prostate cancer, 18F-choline PET-CT represents a single step, whole-body, noninvasive study that allows disease detection and localisation. "
09/01/2008 - "The aim of this study was to evaluate the role of whole body 18F-choline (FCH) positron emission tomography-computed tomography (PET-CT) in detecting and localising disease recurrence in patients presenting biochemical relapse after radical treatment for prostate cancer. "
11/01/2015 - "18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer."
11/01/2015 - "Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy."
07/01/2010 - "Early monitoring of external radiation therapy by [18F]-fluoromethylcholine positron emission tomography and 3-T proton magnetic resonance spectroscopy: an experimental study in a rodent rhabdomyosarcoma model."
08/01/2010 - "Rodent rhabdomyosarcoma: comparison between total choline concentration at H-MRS and [18F]-fluoromethylcholine uptake at PET using accurate methods for collecting data."
01/01/2010 - "In our series, 18F-choline uptake in benign pathological conditions mainly included sites of inflammation; nevertheless, accumulation in tumour deposits not because PC cannot be excluded, particularly in the brain, where correlative imaging with magnetic resonance is of the utmost importance."
10/01/2006 - "18F-choline uptake by inflammation was lower than that of 2DG in the tissue distribution study, and 18F-choline uptake by abscess wall was significantly lower than that of 2DG in the autoradiography study. "
10/01/2006 - "In the ARG of inflammation, linear or ring-like structures of 2DG uptake were observed in the wall of the abscess, but were not identified with 18F-choline. "
10/01/2006 - "18F-choline uptake by inflammation was lower than that by tumor. "
10/01/2006 - "Both tumor and inflammation uptake of 2DG were higher than those of 18F-choline. "
|2.||Choline (Choline Chloride)
|5.||Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
|6.||Prostate-Specific Antigen (Semenogelase)
|7.||Sodium Fluoride (Ossin)
|9.||Deoxyglucose (2 Deoxy D glucose)
|1.||Drug Therapy (Chemotherapy)
|2.||Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
|3.||Prostatectomy (Retropubic Prostatectomy)